NCT01545141 2023-10-27
Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer
Roswell Park Cancer Institute
Phase 1/2 Terminated
Roswell Park Cancer Institute
Alliance for Clinical Trials in Oncology
Vanderbilt-Ingram Cancer Center
NSABP Foundation Inc
Pfizer